Bibliografía
La documentación científica que respalda y confirma
la eficacia de la Hipertermia Médica y Oncológica es
abundante y acontinuación se alista algunas de las
referencias:
1. Kampinga HH, Konings AWT: Inhibition of repair of
X-ray induced DNA damage by heat: the role of
hyperthermic inhibition of DNA polymerase activity. Rad
Res, 112: 86-98, 1987.
2. Kampinga HH, Dynlacht JR, Dikomey E: Mechanism of
radiosensitization (43 °C) as derived from studies with
DNA repair defective mutant cell lines. Int J
Hyperthermia, 20: 131-139, 2004.
3. Kampinga HH: Cell biological effects of hyperthermia
alone or combined with radiation or drugs: A short
introduction to newcomers in the field. Int J
Hyperthermia, 22: 191-196, 2006.
4. Borys N: Phase I/II study evaluating the maximum
tolerated dose, pharmacokinetics, safety, and efficacy
of approved hyperthermia and lyso-thermosensitive
liposomal doxorubicin in patients with breast cancer
recurrence at the chest wall. ASCO abstracts book, 2010.
5. Vaupel P, Otte J, Manz R: Changes in tumor
oxygenation after localized microwave heating. Prog Clin
Biol Res, 107: 65-74, 1982.
6. Bicher HI, Mitagvaria NP, Bruley DF: Changes in
tumor tissue oxygenation during microwave hyperthermia:
clinical relevance. Adv Exp Med Biol, 180: 901-905,
1984.
7. Wahl ML, Bobyock SB, Leeper DB, Owen CS: Effects of
42 degrees C hyperthermia on intracellular pH in ovarian
carcinoma cells during acute or chronic exposure to low
extracellular pH. Int J Radiat Oncol Biol Phys, 39:
205-212, 1997.
8. Nakano H, Kurihara K, Okamoto M, Toné S, Shinohara
K: Heat-induced apoptosis and p53 in cultured mammalian
cells. Int J Radiat Oncol Biol Phys, 71: 519-529, 1997.
9. Coss RA, Sedar AW, Sistrun SS, Storck CW, Wang PH,
Wachsberger PR: Hsp27 protects the cytoskeleton and
nucleus from the effects of 42 degrees C at pH 6.7 in
CHO cells adapted to growth at pH 6.7. Int J
Hyperthermia, 18: 216-232, 2002.
10. Dayanc BE, Beachy SH, Ostberg JR, Repasky EA:
Dissecting the role of hyperthermia in natural killer
cell mediated anti-tumor responses. Int J Hyperthermia,
24: 41-56, 2008.
11. Hetzel FW, Mattiello J: Interactions of hyperthermia
with other modalities. In: Medical physics monograph n°
16. Biological, physical and clinical aspects of
hyperthermia. Paliwal BR, Hetzel FW and Dewhirst MW
(Eds), pp 30-56, Am Inst Phys, 1987.
12. Manning MR, Cetas TC, Miller RC, Oleson JR, Connor
WG, Gerner EW: Clinical hyperthermia: results of a phase
I trial employing hyperthermia alone or in combination
with external beam or interstitial radiotherapy. Cancer,
49: 205-216, 1982.
13. Dunlop PRC, Hand JW, Dickinson RJ, Field SB: An
assessment of local hyperthermia in clinical practise.
Int J Hyperthermia, 2: 39-50, 1986.
14. Gabriele P, Orecchia R, Ragona R, Tseroni V,
Sannazzari GL: Hyperthermia alone in the treatment of
recurrence of malignant tumors. Cancer, 66: 2191-2195,
1990.
15. Valdagni R: International Consensus Meeting on
Hyperthermia: Final report. Int J Hyperthermia, 6:
839-877, 1990.
16. Shrivastava P, Luk K, Oleson J, Dewhirst M, Pajak T,
Paliwal B, Perez C, Sapareto S, Saylor T, Steeves R:
Hyperthermia quality assurance guidelines. Int J Radiat
Oncol Biol Phys, 16: 571-587, 1989.
17. Emami B, Stauffer P, Dewhirst MW, Prionas S, Ryan T,
Corry P, Herman T, Kapp DS, Myerson RJ, Samulski T,
Sapareto S, Sapozink M, Shrivastava P, Waterman F: RTOG
quality assurance guidelines for interstitial
hyperthermia. Int J Radiat Oncol Biol Phys, 20:
1117-1124, 1991.
18. Sapozink MD, Corry PM, Kapp DS, Myerson RJ, Dewhirst
MW, Emami B, Herman T, Prionas S, Ryan T, Samulski T,
Sapareto S, Sapozink M, Shrivastava P, Waterman F: RTOG
quality assurance guidelines for clinical trials using
hyperthermia for deep-seated malignancy. Int J Radiat
Oncol Biol Phys, 20: 1109-1115, 1991.
19. Waterman FM, Dewhirst MW, Fessenden P, Samulski TV,
Stauffer P, Emami B, Corry P, Prionas SD, Sapozink M,
Herman T, Kapp DS, Myerson RJ, Ryan T, Sapareto SA,
Shrivastava P: RTOG quality assurance guidelines for
clinical trials using hyperthermia administered by
ultrasound. Int J Radiat Oncol Biol Phys, 20: 1099-1107,
1991.
20. Kikuchi M, Amemiya Y, Egawa S, Onoyama Y, Kato H,
Kanai H, Saito Y, Tsukiyama I, Hiraoka M, Mizushina S,
Yamashita T, Nikawa Y, Matsuda J, Miyakawa M: Guide to
the use of hyperthermia equipment. 2. Microwave heating.
The Japanese Society of Hyperthermic Oncology. Int J
Hyperthermia, 9: 341-360, 1993.
21. van der Zee J, Vujaskovic Z, Kondo M, Sugahara T:
The Kadota Fund International Forum 2004-clinical group
consensus. Int J Hyperthermia, 24: 111-122, 2008.
22. Overgaard J: The current and potential role of
hyperthermia in radiotherapy. Int J Radiat Oncol Biol
Phys, 16: 535-549, 1989.
23. Valdagni R, Amichetti M: Report of long-term
follow-up in a randomized trial comparing radiation
therapy and radiation therapy plus hyperthermia to
metastatic lymph nodes in stage IV head and neck
patients. Int J Radiat Oncol Biol Phys, 28: 163-169,
1994.
24. Overgaard J, Gonzalez Gonzalez D, Hulshof MC,
Arcangeli G, Dahl O, Mella O, Bentzen SM: Hyperthermia
as an adjuvant to radiation therapy of recurrent or
metastatic malignant melanoma. A multicentre randomized
trial by the European Society for Hyperthermic Oncology.
Int J Hyperthermia, 12: 3-20, 1996.
25. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB,
van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD,
González González D, Liu FF, Goodman P, Sherar M:
Radiotherapy with or without hyperthermia in the
treatment of superficial localized breast cancer:
results from five randomized controlled trials.
International Collaborative Hyperthermia Group. Int J
Radiat Oncol Biol Phys, 35: 731-744, 1996.
26. Wang J, Li D, Chen N: Intracavitary microwave
hyperthermia combined with external irradiation in the
treatment of esophageal cancer. Zhonghua Zhong Liu Za
Zhi, 18: 51-54, 1996.
27. Issels RD, Lindner LH, Wust P, Hohenberger P, Jauch
K, Daugaard S, Mansmann U, Hiddemann W, Lay J, Verwei J:
Regional hyperthermia improves response and survival
when combined with systemic chemotherapy in the
management of locally advanced, high grade soft tissue
sarcomas of the extremities, the body wall and the
abdomen: A phase III randomised prospective study. J
Clin Oncol, 25: 18S (June 20 Suppl): 10009, 2007.
28. Prosnitz LR, Maguire P, Anderson JM, Scully SP,
Harrelson JM, Jones EL, Dewhirst M, Samulski TV, Powers
BE, Rosner GL, Dodge RK, Layfield L, Clough R, Brizel
DM: The treatment of high-grade soft tissue sarcomas
with preoperative thermoradiotherapy. Int J Radiat Oncol
Biol Phys, 45: 941-949, 1999.
29. van der Zee J, Gonzáles Gonzáles D, van Rhoon GC,
van Dijk JDP, van Putten WLJ, Hart AAM: Comparison of
radiotherapy alone with radiotherapy plus hyperthermia
in locally advanced pelvic tumours: a prospective,
randomized multicentre trial. Dutch Deep Hyperthermia
Group. Lancet, 355: 1119-1125, 2000.
30. Berdov BA, Menteshashvili GZ: Thermoradiotherapy of
patients with locally advanced carcinoma of the rectum.
Int J Hyperthermia, 6: 881-890, 1990.
31. Combined use of hyperthermia and radiation therapy
for treating locally advanced cervical carcinoma. The
Cochrane Collaboration, John Wiley & Sons, Ltd. 2010.
32. The Cochrane Collaboration: Concomitant hyperthermia
and radiation therapy for treating locally advanced
rectal cancer. John Wiley & Sons, Ltd., 2009.
33. Sneed PK, Stauffer PR, McDermott MW, Diederich CJ,
Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malek
MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA,
Phillips TL, Gutin PH: Survival benefit of hyperthermia
in a prospective randomized trial of brachytherapy boost
+/- hyperthermia for glioblastoma multiforme. Int J
Radiat Oncol Biol Phys, 40: 287-295, 1998.
34. Jones EL, Oleson JR, Prosnitz LR, Samulski TV,
Vujaskovich Z, Yu D, Sanders LL, Dewhirst MW: Randomized
trial of hyperthermia for superficial tumors. J Clin
Oncol, 23: 3079-3085, 2005.
35. van der Zee J, Treurniet-Donker AD, The SK, Helle
PA, Seldenrath JJ, Meerwaldt JH, Wijnmaalen AJ, van den
Berg AP, van Rhoon GC, Broekmeyer-Reurink MP, Reinhold
HS: Low dose reirradiation in combination with
hyperthermia: a palliative treatment for patients with
breast cancer recurring in a previously irradiated
areas. Int J Radiat Oncol Biol Phys, 15 (6): 1407-1413,
1988.
36. Gabbani M, Giudici S, Dall’Oglio S, Romano M,
Franchi M, Maluta S: Clinical impact of adding
hyperthermia in patients affected by locally advanced
cervical cancer treated with chemo-radiotherapy: the
experience of Verona multidisciplinary group. 10th
International Congress on Hyperthermic Oncology, Munich,
2008.
37. Romano M, Maluta S, Cordiano C, Delaini GG, Genna M,
Oliani C, Capelli P, Tomezzoli A, Manfrini C, Porcaro
AB, Gabbani M, Chierego G: Pre-operative
radio-chemotherapy plus regional hyperthermia in the
treatment of advanced rectal cancer: experience with
radiation dose escalation. Int J Radiat Oncol Biol Phys,
57: S386-387, 2003.
38. Maluta S, Romano M, Dall'Oglio S, Genna M, Oliani C,
Pioli F, Gabbani M, Marciai N, Palazzi M: Regional
hyperthermia added to intensified preoperative
chemo-radiation in locally advanced adenocarcinoma of
middle and lower rectum. Int J Hyperthermia, 26:
108-117, 2010.
39. Palazzi M, Dall’Oglio S, Romano M, Maluta S: Is deep
hyperthermia added to chemo-radiotherapy useful in the
treatment of locally advanced anal cancer? Verona
mono-institutional experience (2000-2006). Tumori, 7:
S151, 2008.
40. Maluta S, Dall’Oglio S, Romano M, Marciai N, Pioli
F, Giri MG, Benecchi PL, Comunale L, Porcaro AB:
Conformational radiotherapy plus local hyperthermia in
patients affected by locally advanced high risk prostate
cancer: preliminary results of a prospective phase II
study. Int J Hyperthermia, 23: 451-456, 2007.
41. Romano M, Palazzi M, Maluta S, Porcaro A:
Radiothérapie conformationelle avec modulation
d’intensité, hyperthermie profonde régionale et
suppression androgénique totale chez des patients
atteints d’une tumeur prostatique à haut risque, opérée
ou non. Résultats préliminaires chez 20 patients. Cancer
Radiothérapie, 13: 687, 2009.
42. Abstract book of ESHO 2010, Rotterdam, May 20-22,
2010.
43. Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG,
Hoogenraad WJ, van Dijk JD, Wárlám-Rhodenhuis CC, Jobsen
JJ, van Rohon GC, van der Zee J: Long-term improvement
in treatment outcome after radiotherapy and hyperthermia
in locoregional advanced cervix cancer: un update of the
Dutch Deep Hyperthermia Trial. Int J Radiat Biol Phys,
15: 1176-1182, 2008.
44. Franckena M, Lutgens LC, Koper PC, Kleinen CE, van
der Steen-Banasik EM, Jobsen JJ, Leer JW, Creutzberg CL,
Dielwart MF, van Norden Y, Canters RA, van Rhoon GC, van
der Zee J: Radiotherapy and hyperthermia for treatment
of primary locally advanced cervix cancer: results in
378 patients. Int J Radiat Oncol Biol Phys, 73: 242-250,
2009. |